Literature DB >> 1524070

Overview of health-related quality-of-life measures.

L D MacKeigan1, D S Pathak.   

Abstract

Quality of life (QOL) as a measurable health-care outcome is discussed, and an overview of the field of QOL assessment is provided. QOL assessments can be used to evaluate drugs in clinical trials, to evaluate provider performance, and to monitor the progress of patients receiving drug therapy. QOL information is most useful in evaluating drug therapy when the primary purpose of a drug is palliative rather than curative, when a drug is somewhat effective but also fairly toxic, when lifelong therapy is administered to prevent complications of a relatively asymptomatic disease, and when there are several equally effective therapies for a specific condition but the adverse-effect profiles differ. Contemporary QOL questionnaires are completed by patients, and they most commonly include dimensions of physical function, mental or cognitive function, emotional or psychological function, social and role function, disease symptoms, and perceptions of well-being. The keys to successful QOL assessment in clinical practice will be selection of instruments that are practical to administer and are capable of detecting small changes in health, selective application of those instruments to patient populations most likely to benefit from this more intensive form of monitoring, and efficient use of data management systems. The consumer of QOL literature must assess the validity of QOL data obtained in a given study and their applicability to his or her practice setting.

Entities:  

Mesh:

Year:  1992        PMID: 1524070

Source DB:  PubMed          Journal:  Am J Hosp Pharm        ISSN: 0002-9289


  22 in total

1.  Carrier testing of children for two X linked diseases in a family based setting: a retrospective long term psychosocial evaluation.

Authors:  O Järvinen; A M Aalto; A E Lehesjoki; M Lindlöf; I Söderling; A Uutela; H Kääriäinen
Journal:  J Med Genet       Date:  1999-08       Impact factor: 6.318

Review 2.  Subjective outcome measurement--a primer.

Authors:  M P Tully; J A Cantrill
Journal:  Pharm World Sci       Date:  1999-06

Review 3.  A review of the health-related quality of life literature in bipolar disorder.

Authors:  M A Namjoshi; D P Buesching
Journal:  Qual Life Res       Date:  2001       Impact factor: 4.147

Review 4.  The expanding role of pharmacy and therapeutics committees. The 1990s and beyond.

Authors:  W E Wade; W J Spruill; A T Taylor; R L Longe; D W Hawkins
Journal:  Pharmacoeconomics       Date:  1996-08       Impact factor: 4.981

5.  Health-related quality of life deficits associated with diabetes and comorbidities in a Canadian National Population Health Survey.

Authors:  Sheri L Maddigan; David H Feeny; Jeffrey A Johnson
Journal:  Qual Life Res       Date:  2005-06       Impact factor: 4.147

6.  Patient reported outcome measures: a model-based classification system for research and clinical practice.

Authors:  Jose M Valderas; Jordi Alonso
Journal:  Qual Life Res       Date:  2008-10-03       Impact factor: 4.147

7.  Measurement of speech effort during fluency-inducing conditions in adults who do and do not stutter.

Authors:  Roger J Ingham; Anne K Bothe; Erin Jang; Lauren Yates; John Cotton; Irene Seybold
Journal:  J Speech Lang Hear Res       Date:  2009-08-20       Impact factor: 2.297

8.  Quality of life assessment by community pharmacists: an exploratory study.

Authors:  J P Bentley; M C Smith; B F Banahan; D A Frate; B R Parks
Journal:  Qual Life Res       Date:  1998-02       Impact factor: 4.147

9.  Definitions of quality of life: what has happened and how to move on.

Authors:  Marcel W M Post
Journal:  Top Spinal Cord Inj Rehabil       Date:  2014

10.  Reliability and Validity of the Korean Version of QOLIE-10 in Epilepsy.

Authors:  Sang-Ahm Lee; Sung-Cheol Yun; Byung-In Lee
Journal:  J Clin Neurol       Date:  2006-12-20       Impact factor: 3.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.